 |
|  | Diabetes Overview
Facts and Figures
Diabetes is reaching epidemic proportions. Worldwide, the number of cases is
expected to double to 300 million in less than 25 years. Today, over 5 million
people worldwide live with Type 1 diabetes (the more severe form of the disease),
of which almost 395,000 are children. If left untreated, long-term complications
of the disease can lead to heart failure, blindness, impotence, kidney failure,
amputation, and in many cases death. Tight glycaemic control is central to good
health, as proven by numerous studies, including the landmark Diabetes
Control and Complications Trial (DCCT), which concluded in 1993.
European Region
- UK - Over 1.4 million adults are diagnosed with
diabetes, and between 138,000 and 345,000 adults have Type 1 diabetes
- France - Over 1.6 million are affected, and
more than 97,000 have Type 1 diabetes.
- Germany - 2.6 million are affected, and more
than 197,000 have Type 1 diabetes.
- Italy - Over 3.1 million are affected, and more
than 97,000 have Type 1 diabetes.
- Spain - Over 2 million are affected, and more
than 96,000 have Type 1 diabetes.
- Netherlands - Over 415,000 are affected, and
more than 41,000 have Type 1 diabetes.
- Sweden / Finland - Almost 730,000 are affected,
and more than 90,000 have Type 1 diabetes.
- Poland - Over 1.5 million are affected, and
more than 41,000 have Type 1 diabetes.
- Turkey - Over 1.8 million are affected, and
more than 65,000 have Type 1 diabetes.
Diabetes Atlas 2000 (ages 20-79),
Diabetes in the United Kingdom - 1996, A British Diabetic Association Report
What is diabetes ?
Diabetes prevents the body from properly using energy from food. The condition
occurs when the pancreas produces little or no insulin, a hormone required to
sustain life, or when the pancreas makes insulin, but the body resists it.
- Insulin, a hormone required to sustain life
Insulin is a hormone produced by the Pancreas to aid accessing to the energy
stored in the food. Largely this results from the ability of the body, under
the influence of Insulin, to release sugar from the food intake, to store
it and to use it, when needed, to drive our normal functions.
- The normal stability of blood sugar levels
The normal metabolic process of releasing glucose from the food intake ensures
that the amount of sugar in our blood remains within the region of 3.5 to
4.5 mmol/l(60-80 mg/100ml). Insulin levels rise when we have a meal in order
to capture the sugar from the food intake. Insulin levels reduce after the
processing of the food intake over a period of approximately 2 hours. During
the rest of the day, an associated mechanism prevents blood sugar levels from
falling below the normal levels by releasing glucose from the body storage
areas in fat and tissues.
- The Diabetes disease
Diabetes is a description of the condition where there is a mismatch between
the food intake and the levels of production or utilisation of Insulin.
- In Type 1 diabetes,
the pancreas no longer produces insulin, an important hormone that helps
metabolise glucose and supply energy to cells. A person with this condition
must administer insulin using injections or an
insulin pump.
- Type 2 diabetes is a metabolic disorder
resulting from the body's inability to make enough, or properly use, insulin.
Type 2 diabetes is often controlled by diet and exercise, oral medications
and, in some cases, insulin. Research indicates that obesity and weight
gain are associated with an increased risk of Type 2 diabetes. Insulin
pumps have been successfully used to treat Type 2 patients requiring insulin
and with poor glycaemic control.
Without an adequate availability of insulin, a
person is unable to get energy from food or to keep glucose levels in balance.
Poor glucose control can lead to acute complications from hypoglycaemia
(low blood glucose) or hyperglycaemia (a condition associated with higher-than-normal
blood glucose), which can lead to ketoacidosis, causing coma or death, if left
untreated. Diabetes is the leading cause of blindness, kidney failure and amputation,
and is a major factor in cardiovascular disease and nerve damage.
|